Your browser doesn't support javascript.
loading
Linkage-Editing Pseudo-Glycans: A Reductive α-Fluorovinyl-C-Glycosylation Strategy to Create Glycan Analogs with Altered Biological Activities.
Moriyama, Takahiro; Yoritate, Makoto; Kato, Naoki; Saika, Azusa; Kusuhara, Wakana; Ono, Shunsuke; Nagatake, Takahiro; Koshino, Hiroyuki; Kiya, Noriaki; Moritsuka, Natsuho; Tanabe, Riko; Hidaka, Yu; Usui, Kazuteru; Chiba, Suzuka; Kudo, Noyuri; Nakahashi, Rintaro; Igawa, Kazunobu; Matoba, Hiroaki; Tomooka, Katsuhiko; Ishikawa, Eri; Takahashi, Shunji; Kunisawa, Jun; Yamasaki, Sho; Hirai, Go.
Afiliação
  • Moriyama T; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Yoritate M; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Kato N; Faculty of Agriculture, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.
  • Saika A; RIKEN Center for Sustainable Resource Science, 2-1, Hirosawa, Wako, Saitama 351-0198, Japan.
  • Kusuhara W; Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition, 7-6-8 Asagi-Saito, Ibaraki, Osaka 567-0085, Japan.
  • Ono S; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, 11 Biopolis Way, Helios, Singapore 138667, Singapore.
  • Nagatake T; Research Institute for Microbial Diseases, Osaka University, Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Koshino H; Immunology Frontier Research Center, Osaka University, Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Kiya N; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Moritsuka N; Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition, 7-6-8 Asagi-Saito, Ibaraki, Osaka 567-0085, Japan.
  • Tanabe R; Department of Life Sciences, School of Agriculture, Meiji University, 1-1-1 Higashi-Mita, Tama, Kawasaki, Kanagawa 214-8571, Japan.
  • Hidaka Y; RIKEN Center for Sustainable Resource Science, 2-1, Hirosawa, Wako, Saitama 351-0198, Japan.
  • Usui K; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Chiba S; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Kudo N; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Nakahashi R; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Igawa K; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Matoba H; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Tomooka K; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Ishikawa E; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Takahashi S; Institute for Materials Chemistry and Engineering, IRCCS, Kyushu University, Kasuga, Fukuoka 816-8580, Japan.
  • Kunisawa J; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Yamasaki S; Institute for Materials Chemistry and Engineering, IRCCS, Kyushu University, Kasuga, Fukuoka 816-8580, Japan.
  • Hirai G; Research Institute for Microbial Diseases, Osaka University, Yamadaoka, Suita, Osaka 565-0871, Japan.
J Am Chem Soc ; 146(3): 2237-2247, 2024 01 24.
Article em En | MEDLINE | ID: mdl-38196121
ABSTRACT
The acetal (O-glycoside) bonds of glycans and glycoconjugates are chemically and biologically vulnerable, and therefore C-glycosides are of interest as more stable analogs. We hypothesized that, if the O-glycoside linkage plays a vital role in glycan function, the biological activities of C-glycoside analogs would vary depending on their substituents. Based on this idea, we adopted a "linkage-editing strategy" for the creation of glycan analogs (pseudo-glycans). We designed three types of pseudo-glycans with CH2 and CHF linkages, which resemble the O-glycoside linkage in terms of bond lengths, angles, and bulkiness, and synthesized them efficiently by means of fluorovinyl C-glycosylation and selective hydrogenation reactions. Application of this strategy to isomaltose (IM), an inducer of amylase expression, and α-GalCer, which activates iNKT cells, resulted in the discovery of CH2-IM, which shows increased amylase production ability, and CHF-α-GalCer, which shows activity opposite that of native α-GalCer, serving as an antagonist of iNKT cells.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polissacarídeos / Galactosilceramidas / Glicosídeos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polissacarídeos / Galactosilceramidas / Glicosídeos Idioma: En Ano de publicação: 2024 Tipo de documento: Article